Xenical
Rabeprazole
Clindamycin
Fluconazole
Pravastatin

Values are mean SD ; or number % ; where appropriate. P for trend across groups all are 0.001 except for pravastatin use P 0.76 ; . CKD, chronic kidney disease; MI, myocardial infarction; BMI, body mass index; MDRD, Modification of Diet in Renal Disease. Despite its high prevalence, hypertension is not well controlled in the United States. According to the latest update of the National Health and Nutrition Examination Survey, NHANES III, 20% of participants aged 18 to 74 years suffered from hypertension, which is defined as having a mean systolic blood pressure SBP ; 140 mm Hg, having a mean diastolic blood pressure DBP ; 90 mm Hg, or being prescribed medication for hypertension. Of these, 30% were previously unaware of their hypertension, 18% were aware of their condition but their disease was neither treated nor controlled, 27% were being treated but their disease was not under control, and only 25% were both being treated and had their disease controlled.1 Undiagnosed, untreated, and uncontrolled hypertension clearly places a substantial strain on the health care delivery system.2 It is our role as pharmacy practitioners to assist in the management of hypertension, in an effort to decrease the prevalence of undiagnosed, untreated, and uncontrolled hypertension. As pharmacists, we have the knowledge and expertise to assist health care providers in ensuring that patients are receiving the appropriate antihypertensive agent based on their medical history, response to existing or previous therapy, adverse drug reactions, and current medical literature, for instance, lovastatin pravastatin. Product rating: buy at: sundrugstore: $16 75 medstore: $18 09 $169 - $182 from 2 store s ; pravastatin 10 mg 240 pill pravachol pravastatin ; is an hmg-coa reductase inhibitor also known as a statin ; used to lower cholesterol and triglyceride levels in your blood!
The author is employed by the Norwegian government, which has a substantial interest in improving professional practice in Norway and in containing the costs of healthcare. He is also conducting a trial of implementation strategies for guidelines for the management of hypertension and hypercholesterolaemia, for instance, pravastatin cholesterol.

Side affects of pravastatin sodium

Consequently, fda urges patients who use these two drugs to continue taking their tablets and to talk with their health care provider about possible alternative products for use until the manufacturing problems have been corrected.
In the IBS Medications Side Effects Study, many of the IBS patients with constipation experienced adverse effects from medications, including abdominal cramping, bloating, drowsiness, and dizziness. For example, approximately 60% of survey respondents taking OTC laxatives n 112 ; , prescription laxatives n 59 ; , or prescription antidepressants n 87 ; and close to 70% of patients taking prescription anti-anxiety medications n 88 ; experienced adverse effects. Additionally, nearly 40% of respondents taking OTC fiber supplements n 263 ; and 50% of patients taking prescription antispasmodics n 189 ; also reported adverse effects. Most of the survey respondents considered these adverse effects to be mild or moderate. A limitation of these findings is the fact that the degree to which these reported adverse effects were truly caused by the medications could not be assessed and prograf. Gabapentin lamotrigine meloxicam meloxicam sertraline tamsulosin terbinafine appendix 2: rising use of generics in the uk statins market market developments atorvastatin fluvastatin pravastatin rosuvastatin simvastatin appendix 3: generics in the uk ppi market esomeprazole lansoprazole omeprazole pantoprazole rabeprazole sodium appendix 4: sources espicom sources uk government sources industry sources appendix 5: directory regulators trade bodies manufacturers.

Pravastatin with alcohol

Synopsis A British study in the Pharmaceutical Journal has reported that 25% of patients in primary care are noncompliant with statin therapy. The retrospective cohort study was conducted in a GP practice in Liverpool 10 GPs, 12, 700 patients ; from Dec 1991 to Jan 2003. A total of 1010 patients were prescribed a statin during this period, of which 869 met the study's inclusion criteria. A total of 654 were classified as compliant and 215 as non-compliant. There was no statistically significant difference between the compliant and non-compliant groups. Analysis of the data showed the following: The risk of a fatal CHD event was significantly lower p 0.0043, relative risk reduction 44% ; in those patients compliant with their prescribed therapy. Compliance with therapy was associated with a significant reduction in CHD mortality p 0.0088, RRR 56% ; and non-cardiovascular mortality p 0.055, RRR 63% ; . The risk of an event in the non-compliant subgroup was found to be 2.542 times 95% CI 1.310- 4.933 ; times greater. Cholesterol monitoring was a statistically significant predictor p 0.001 ; of patient compliance. Diabetics were the most likely to be receiving this service p 0.001 ; . The authors conclude that there is a need to implement compliance enhancing initiatives, such as regular cholesterol monitoring and tacrolimus, because pravastatin price.

6. Nissen SE, Nicholls SJ, Sipahi I, et al; ASTEROID Investigators. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The ASTEROID trial. JAMA 2006; 295: 1556-65. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333: 1301-7. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS TexCAPS. Air Force Texas Coronary Atherosclerosis Prevention Study. JAMA 1998; 279: 1615-22. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study 4S ; . Lancet 1994; 344: 1383-9. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average.
There have been reports of a serious drug interaction between cyclosporine and the herbal dietary supplement, St. John's Wort. This interaction has been reported to produce a marked reduction in the blood concentrations of cyclosporine, resulting in subtherapeutic levels, rejection of transplanted organs, and graft loss. Rifabutin is known to increase the metabolism of other drugs metabolized by the cytochrome P-450 system. The interaction between rifabutin and cyclosporine has not been studied. Care should be exercised when these two drugs are administered concomitantly. Nonsteroidal Anti-inflammatory Drug NSAID ; Interactions: Clinical status and serum creatinine should be closely monitored when cyclosporine is used with nonsteroidal anti-inflammatory agents in rheumatoid arthritis patients. See WARNINGS ; Pharmacodynamic interactions have been reported to occur between cyclosporine and both naproxen and sulindac, in that concomitant use is associated with additive decreases in renal function, as determined by 99m Tc-diethylenetriaminepentaacetic acid DTPA ; and p-aminohippuric acid ; PAH clearances. Although concomitant administration of diclofenac does not affect blood levels of cyclosporine, it has been associated with approximate doubling of diclofenac blood levels and occasional reports of reversible decreases in renal function. Consequently, the dose of diclofenac should be in the lower end of the therapeutic range. Methotrexate Interaction: Preliminary data indicate that when methotrexate and cyclosporine were coadministered to rheumatoid arthritis patients N 20 ; , methotrexate concentrations AUCs ; were increased approximately 30% and the concentrations AUCs ; of its metabolite, 7-hydroxy methotrexate, were decreased by approximately 80%. The clinical significance of this interaction is not known. Cyclosporine concentrations do not appear to have been altered N 6 ; . Other Drug Interactions: Cyclosporine may reduce the clearance of digoxin, colchicine, prednisolone and HMG-CoA reductase inhibitors statins ; . Severe digitalis toxicity has been seen within days of starting cyclosporine in several patients taking digoxin. There are also reports on the potential of cyclosporine to enhance the toxic effects of colchicine such as myopathy and neuropathy, especially in patients with renal dysfunction. If digoxin or colchicine are used concurrently with cyclosporine, close clinical observation is required in order to enable early detection of toxic manifestations of digoxin or colchicine, followed by reduction of dosage or its withdrawal. Literature and postmarketing cases of myotoxicity, including muscle pain and weakness, myositis, and rhabdomyolysis, have been reported with concomitant administration of cyclosporine with lovastatin, simvastatin, atorvastatin, pravastatin, and, rarely, fluvastatin. When concurrently administered with cyclosporine, the dosage of these statins should be reduced according to label recommendations. Statin therapy need to be temporarily withheld or discontinued in patients with signs and symptoms of myopathy or those with risk factors predisposing to severe renal injury, including renal failure, secondary to rhabdomyolysis. Cyclosporine should not be used with potassium-sparing diuretics because hyperkalemia can occur. During treatment with cyclosporine, vaccination may be less effective. The use of live vaccines should be avoided. Frequent gingival hyperplasia with nifedipine, and convulsions with high dose methylprednisolone have been reported. Psoriasis patients receiving other immunosupressive agents or radiation therapy including PUVA and UVB ; should not receive concurrent cyclosporine because of the possibility of excessive immunospression and pantoprazole!

33 a randomized trial of the efficacy and safety of fenofibrate versus pravastatin in hiv-infected subjects with lipid abnormalities: aids clinical trials group study 508 aids res hum retroviruses 21 : 757-6 2005.

Pravastatin sod tab side effects

What should i avoid while taking aspirin and pravastatin and pentoxifylline.

Christian guilleminault, md * stanford university school of medicine, stanford, california * correspondence to christian guilleminault, sleep disorders center, stanford university school of medicine, 701 welch road, suite 2226, palo alto, ca 94304 this journal is listed in the national library of medicine's pubmed index.

Pravastatin 40 picture

Activity of Pgp.149 In human pharmacokinetic studies, carvedilol, the most efficient Pgp inhibitor of the beta-adrenoceptor antagonists tested, has shown to increase bioavailability of digoxin, but the clinical relevance has to be determined.150, 151 In analogy, concomitant administration of simvastatin, lovastatin and atorvastatin may increase digoxin serum concentrations up to 20%, because of the inhibition of Pgp-mediated transport.141, 152 On the other hand, pravastatin did not show alterations in the pharmacokinetics of digoxin, 152, 153 and the effect of fluvastatin seems not to be clinically relevant.154 Therapeutic drug monitoring may help to prevent toxic effects associated with higher digoxin concentrations. Drugs used in the treatment of arrhythmias were also often involved in pDDIs. The most common pDDIs with antiarrhythmics identified in our study were the pharmacokinetic interactions involving amiodarone, diltiazem or verapamil in combination with atorvastatin or simvastatin. Amiodarone, diltiazem and verapamil are inhibitors of different hepatic CYP isozymes, in particular CYP 3A4.100-102 CYP 3A4 is primarily responsible for the metabolism of simvastatin, atorvastatin and lovastatin. Since the occurrence of myotoxicity associated with statins is considered to be dose-dependent, 142, 155-157 pDDIs of CYP 3A4 inhibitors with simvastatin, atorvastatin or lovastatin are associated with an increased risk for rhabdomyolysis.158 In addition, older patients, particularly thin or frail women, or those with multisystem diseases, in particular patients with renal failure, seem to be at higher risk for statinassociated myopathy and should therefore be monitored carefully for early signs of muscle discomfort or weakness.142, 155 In our study, the prevalence of depression and psychiatric disorders was highest in patients aged 54 years and was identified as a risk factor for pDDIs in this age group. Several reasons may contribute to this observation, which may not accurately reflect the age-dependent prevalence of depression.159 Considering the low prevalence of psychiatric disorders compared with the amount of centrally acting drugs prescribed, it can be assumed that the physicians did not report all psychiatric disorders in elderly patients. In addition, depression is often underdiagnosed and undertreated in the elderly, because somatic symptoms may predominate or dementia and or comorbid medical illnesses may complicate the recognition of depressive symptoms.160, 161 Patients aged 54 years had a higher prevalence of and trental.
Pravastatin na pravastatin
SQ-27427 h.t. THROMBOXANE-ANTAGONISTS ANTIAGGREGANTS TRIAL-PREP. FOSINOPRILAT SQ-27519 ANTIBIOTICS TRIAL-PREP. HYPOTENSIVES TRIAL-PREP. ANGIOTENSIN-ANTAGONISTS ACE-INHIBITORS DIURETICS TRIAL-PREP. ANTIBIOTICS SQ-29548 CORTICOSTEROIDS TRIAL-PREP. ANGIOTENSIN-ANTAGONISTS ACE-INHIBITORS TRIAL-PREP. TRIAL-PREP. SYNERGISTS TRIAL-PREP. SYNERGISTS FOSINOPRIL SQ-28555 FOSENOPRIL FOSFENOPRIL PEPTIDE-HYDROLASE-INHIBITORS NEUTRAL-ENDOPEPTIDASE- INHIBITORS TRIAL-PREP. ANTIAGGREGANTS TRIAL-PREP. THROMBOXANE-ANTAGONISTS PROSTAGLANDIN-ANTAGONISTS ANTIAGGREGANTS THROMBOXANE-ANTAGONISTS TRIAL-PREP. TRIAL-PREP. PEPTIDE-HYDROLASE- INHIBITORS THROMBOXANE-ANTAGONISTS ANTIINFLAMMATORIES ANTIAGGREGANTS TRIAL-PREP. ANTIAGGREGANTS THROMBOXANE-ANTAGONISTS TRIAL-PREP. CERONAPRIL CERANAPRIL SQ-29852 TIGEMONAM TEBOROXIME SQ-30217 TIGEMONAM TRIAL-PREP. THROMBOXANE-ANTAGONISTS TIGEMONAM sq-34514 use was s.a. and also sq-31000 use was and or h.t. h.t. h.t. h.t. h.t. h.t. h.t. h.t. PRAVASTATIN SODIUM CS-514 EPTASTATIN SQ-31000 TRIAL-PREP. ANTIARTERIOSCLEROTICS CALCIUM-ANTAGONISTS TRIAL-PREP. TRIAL-PREP. CORTICOSTEROIDS CORTICOSTEROIDS TRIAL-PREP. CORTICOSTEROIDS TRIAL-PREP. TRIAL-PREP. ANTIARTERIOSCLEROTICS TRIAL-PREP. TRIAL-PREP. RADIOPAQUES IMAGING-AGENTS TRIAL-PREP. TRIAL-PREP. HYPOTENSIVES CALCIUM-ANTAGONISTS GADOTERIDOL SQ-32692 SORIVUDINE BROMOVINYLARAURIDINE-5 VIRUCIDES TRIAL-PREP. CYCLOBUT-G SQ-33054 LOBUCAVIR A-75179 A-75962 ANTIAGGREGANTS TRIAL-PREP. THROMBOXANE-ANTAGONISTS TRIAL-PREP. HYPOTENSIVES CALCIUM-ANTAGONISTS TRIAL-PREP. THROMBOXANE-ANTAGONISTS ANTIAGGREGANTS ANTIARTERIOSCLEROTICS TRIAL-PREP. RENIN-INHIBITORS TRIAL-PREP. ANGIOTENSIN-ANTAGONISTS TRIAL-PREP. ANTIAGGREGANTS ANTIASTHMATICS BRONCHODILATORS VASODILATORS THROMBOXANE-ANTAGONISTS LOBUCAVIR SQ-34514 CYCLOBUT-G A-75179 A-75962.

Pravastatin cholesterol medication

The emergence of resistance to commercially available antifungal compounds is increasing and there is much interest in the development of new antifungal drugs or combination therapy of antifungal agents with other agents to improve efcacy or decrease toxicity, or both [1]. In 1997, Chin et al. reported synergy between uvastatin, a cholesterol-lowering agent, and uconazole and itraconazole by both checkerboard and timekill studies against Candida albicans and Cryptococcus neoformans [2]. However, the concentrations of uvastatin used 4 32 mg L ; were not clinically achievable. The reported Cmax for uvastatin after doses of 2040 mg day ranged from 100 to 300 ng ml [3]. The potential utility of combination therapy of uconazole and statins is unclear, as the concentrations of uvastatin used by Chin et al. were clinically unachievable. These investigators also found that pravastatin, lova and pheniramine.
2 ST. LOUIS COLLEGE OF PHARMACY, for example, pravastaton sodium 40 mg.

Prevention of coronary heart disease with pravastatiin in men with

Pravastatin trade names
NOTE: Adverse effects and side effects were chosen for inclusion in this listing based upon their potential severity, cost and frequency, and the clinical experience of the pharmacist advisory panel. This listing is not intended to identify all possible adverse effects and the healthcare professional should consult other sources of drug information as necessary. Instructions: Interpretive Guideline F272 xiv ; Drug therapy Please draw a circle around the drug s ; that are ordered for this resident. When drug s ; are discontinued, "Drug therapy" is defined as all prescription and over-the-counter medications taken by the resident, including dosage, frequency of administration, and recognition of significant side effects that would be most likely to occur in the resident. strike through the circle. A resident is not likely to experience all of the listed side effects adverse effects The information need not appear in the assessment. However, it must be in the resident's clinical record and included in associated with each medication. You may choose to highlight the effects that you believe are particularly the care plan. likely for this individual resident and progesterone. Refer to nz ps pharmac page 31 for details. 27. Miossec P, Zkhiri F, Paries J, David-Dufilho M, Devynck MA, Valensi PE: Effect of pravas6atin on erythrocyte rheological and propafenone.

The current costs of statins are similar, with 10 mg of proprietary simvastatin, atorvastatin and rosuvastatin all costing an identical 235 year. The cost of simvastatin 20 mg, 40 mg or 80 mg daily is identical to that of rosuvastatin 20 mg and 40 mg or atorvastatin 20, 40 and 80 mg all the different statins and dosages retail at about 387 year. This artificial pricing structure at least allows us to use higher doses without worrying about its effect on our drug budgets. Problems with liver function tests and CPK levels Many diabetic patients have minor elevations of liver enzymes, usually due to fatty infiltration. Although statins are stated to be hepatotoxic, severe hepatic necrosis is excessively rare, and this risk is usually far outweighed by the potential benefit in reducing vascular disease. Thus, we have a liberal approach to giving statins unless hepatocellular enzymes are 3 times the upper limit of normal. Nevertheless, statins should be avoided in patients with overt liver disease, such as alcoholic cirrhosis. Serial LFTs may not be routinely necessary. Myalgia was reported by over 30% of patients in the Heart Protection Study, but the prevalence was similar in both placebo and statin groups, so patients complaining of this symptom may be reading the package insert too assiduously. Severe rhabdomyolysis is very rare and usually occurs either in renal failure or in combination therapy with fibrates. It is worth checking the creatine phosphokinase CPK ; level if patients complain of myalgia, and statins should be stopped if there is more than a 5-fold rise. It is worth remembering that Afro Caribbeans have a markedly raised normal range for CPK. There is some concern that various drugs may interact with statins, increasing the statin levels markedly, and rarely predisposing to rhabdomyolysis. The most important include erythromycin, amiodarone, cyclosporine and diltiazem, and it has been suggested that simvastatin should be withdrawn when taking erythromycin, and that the dose be restricted to 20 mg when taking amiodarone or diltiazem. These problems are not observed with pravastatin. Ezetimibe This new drug inhibits cholesterol absorption from the gut, and acts as a useful adjunct to statins if these drugs don't lower lipid levels sufficiently. It might also be used as monotherapy in patients who can't tolerate statins. It is contraindicated in established liver disease, but otherwise seems safe and useful, although as yet there is little evidence of long-term efficacy in reducing vascular disease. Ezetimibe `Ezetrol' ; is given in a dose of 10 mg daily and costs 343 year. Fibrates Fibrates are well suited for use in diabetes, because they tackle the classic lipid abnormalities of elevated triglycerides and lowered HDL. However, trial data so far is limited, and confined largely to secondary rather than primary prevention, compared with the huge body of evidence on the benefits of statins. The significance of mildly raised triglyceride levels, and the benefits of lowering them, are still unclear. The data suggest that fibrates are indeed beneficial, but unless patients have a grossly raised triglyceride say over 5 mmol l ; and relatively normal cholesterol, statins remain the drugs of.
Statins Statin treatment significantly reduces the number of cardiovascular events, particularly in secondary prevention [64, 65]. For better guidance of cholesterol levels to reduce cardiovascular risk with statins, monitoring of CRP might be helpful, because statins lower LDL cholesterol and CRP. The relationships between LDL cholesterol and CRP levels after treatment with atorvastatin or pravastatin and the risk of recurrent myocardial infarction or death from coronary causes were evaluated among 3745 patients with acute coronary syndromes [66]. Both statins lowered cholesterol levels, although atorvastatin was more likely than pravastatin to result in low levels of LDL cholesterol and CRP. Patients who had LDL cholesterol levels of less than 70 mg dl and CRP levels of less than 1 mg l after statin therapy had the lowest rate of recurrent events, demonstrating that patients who have low CRP levels after statin therapy have better clinical outcomes than those with higher CRP levels, regardless of the resultant level of LDL cholesterol. To further investigate the impact of statin treatment in the primary prevention of cardiovascular disease in patients with low LDLcholesterol but elevated hs-CRP levels, the JUPITER trial has recently been initiated [67]. PPAR gamma activators Other widely described drugs for patients with cardiovascular risk factors like hypertension, metabolic syndrome and type 2 diabetes, peroxysome proliferatoractivated receptor PPAR ; -alpha and -gamma activators, seem to have anti-inflammatory properties. Indeed, PPAR-alpha activators like fenofibrate inhibit myocardial inflammation in angiotensin II-infused and salt-induced hypertensive rats [68, 69]. In a similar model, angiotensin II-induced hypertensive rats received the PPAR-gamma activators pioglitazone or rosiglitazone. Both drugs reduced upregulated cell cycle proteins and pro-inflammatory mediators like NF-kB, VCAM and PECAM and improved endothelial function, and attenuated blood pressure increase and expression of angiotensin II type 1 receptors [70]. The anti-inflammatory effects of pioglitazone seem to be independent of glucose control, as demonstrated recently in a prospective study in 192 patients with type 2 diabetes [71]. Therefore, in view of the evolving epidemic of the metabolic syndrome with arterial hypertension and hyperglycaemia, additional effects of drugs for the control of single components of the metabolic syndrome are important. Cannabinoid receptor antagonist This might hold also for a very new class of drugs interacting with the endocannabinoid system, the cannabinoid-1 receptor in particular. Originally developed to help smoking cessation, rimonabant has favourable effects on body weight, waist circumference and rythmol and pravastatin.

Pravastatin brand name

The meta-analysis was done by using a random-effects model because of between-study heterogeneity P 0.026 ; . 4S Scandinavian Simvastatin Survival Study; CARE Cholesterol and Recurrent Events trial; HPS-2 Heart Protection Study secondary prevention arm LIPID Long-term Intervention with Pravastagin in Ischemic Disease trial; LIPS Lescol Intervention Prevention Study; Post-CABG PostCoronary Artery Bypass Graft trial; PROSPER-2 Prospective Study of Pravastati in the Elderly at Risk secondary prevention arm VAHIT Veterans Administration High-Density Lipoprotein Cholesterol Intervention Trial.
Drug Brand name ; Atorvastatin Lipitor ; Fluvastatin Lescol ; Lovastatin Mevacor ; Pravadtatin Pravachol ; Simvastatin Zocor ; Dosage regimen 10 mg daily 20 mg daily 20 mg daily 10 mg daily 10 mg daily Cost per day23 $1.60 $0.75 $1.73 $1.51 $1.80 and pyrazinamide. This approach could give adequate control of aldehyde evolution. The conclusion could be drawn by HPLC that the contents of outcome were dimer of TP and eletrophilic substituent product. CONCLUSION: The data suggest that TP could scavenge aldehyde both at gaseous and liquid phases, and we put forward that TP acts as antihepatotoxic drug, both at and subsequent to the time of manufacture of the product. Project supported by National High-Tech Research and Development Program of China, No 2002AA2Z3782, and the National Natural Science Foundation of China, No 30171148. Taking 2 x 360 mg tablets in the morning and 2 x 360 mg tablets in the evening. How it is taken: Never crush, chew or cut MYFORTIC tablets. The tablets should be swallowed whole. 2 lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin.

Pravastatin sodium cholesterol

Szczepionka Emulsion inaktywowana przeciw zakazeniom e. coli oraz cl. perfringens Mesalazinum Mesalazinum Szczepionka przeciw kolibakteriozie swin Collistinum Gastro-resistant tablets Suppository Suspension, for example, lovastatin pravastatin.
Pravastatin 20mg tablet

Genotype kits, prednisone recreational, bismuth 213, uric acid msds and sinus of valsalva anatomy. Eyelash 05, dilaudid drug interactions, script 8 femmes and elizabeth blackwell story or cardiomyopathy young people.

Pravastatin 60mg

Side affects of pravastatin sodium, pravastatin with alcohol, pravastatin sod tab side effects, pravastatin 40 picture and pravastatin na pravastatin. Prvastatin cholesterol medication, prevention of coronary heart disease with pravastatin in men with, pravastatin trade names and pravastatin brand name or pravastatin sodium cholesterol.



© 2007-2009 Dur.6te.net -All Rights Reserved.